Bharat Biotech to start Phase-1 clinical trials of Covid-19 nasal vaccine
Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during March this year.
Other Healthcare Videos
Stroke Pe Rok: How AI & Technology Are Revolutionising Stroke Care in India
Quad Cancer Moonshot: PM Modi announces USD 7.5 million support to fight cervical cancer
Mpox outbreak: WHO declares public health emergency of global concern
Study on Covaxin reports adverse events in some participants who took the Covid-19 vaccine
Covishield row: 'Very rare chances…', ex-AIIMS doctor explains severe side-effects of covid vaccine
